Targeting pancreatic cancer stroma by HDAC inhibitors

被引:0
作者
Ghallab, M. A. [1 ]
Rosignoli, G. [1 ]
Escrig, I. S. [1 ]
Hurst, H. C. [1 ]
Hart, I. R. [1 ]
Bhattacharya, S. [1 ]
Kocher, H. M. [1 ]
机构
[1] Queen Mary Univ, Barts Canc Inst, London, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:4 / 4
页数:1
相关论文
共 50 条
[21]   Stroma-targeting strategies in pancreatic cancer: a double-edged sword [J].
Xi Liu ;
Juan Iovanna ;
Patricia Santofimia-Castaño .
Journal of Physiology and Biochemistry, 2023, 79 :213-222
[22]   Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? [J].
Jiang, Bolun ;
Zhou, Li ;
Lu, Jun ;
Wang, Yizhi ;
Liu, Chengxi ;
You, Lei ;
Guo, Junchao .
FRONTIERS IN ONCOLOGY, 2020, 10
[23]   Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects [J].
Faran Polani ;
Patrick M Grierson ;
Kian-Huat Lim .
World Journal of Gastroenterology, 2021, 27 (18) :2105-2121
[24]   Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer [J].
Modi, Shrey ;
Giri, Bhuwan ;
Gupta, Vineet K. ;
Lavania, Shweta ;
Sethi, Vrishketan ;
Sharma, Nikita S. ;
Pandey, Somnath ;
Vickers, Selwyn ;
Dudeja, Vikas ;
Saluja, Ashok K. .
CANCER LETTERS, 2022, 537
[25]   Pancreatic cancer, stroma, and exosomes [J].
Closa, Daniel .
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2023, 79 (01) :205-211
[26]   Pancreatic cancer, stroma, and exosomes [J].
Daniel Closa .
Journal of Physiology and Biochemistry, 2023, 79 :205-211
[27]   Advances in dual-targeting inhibitors of HDAC6 for cancer treatment [J].
Gu, Zhicheng ;
Lin, Shuxian ;
Yu, Junhui ;
Jin, Fei ;
Zhang, Qingqing ;
Xia, Keli ;
Chen, Lei ;
Li, Yan ;
He, Bin .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 275
[28]   Retinoids, in combination with Histone Deacetylase (HDAC) inhibitors, as a potential therapy for pancreatic cancer [J].
Susanto, J. ;
Colvin, E. ;
Scarlett, C. ;
Ong, V. ;
Mawson, A. ;
Pinese, M. ;
Biankin, A. .
EJC SUPPLEMENTS, 2008, 6 (09) :29-29
[29]   Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes [J].
Bantscheff, Marcus ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Dittmann, Antje ;
Grandi, Paola ;
Michon, Anne-Marie ;
Schlegl, Judith ;
Abraham, Yann ;
Becher, Isabelle ;
Bergamini, Giovanna ;
Boesche, Markus ;
Delling, Manja ;
Duempelfeld, Birgit ;
Eberhard, Dirk ;
Huthmacher, Carola ;
Mathieson, Toby ;
Poeckel, Daniel ;
Reader, Valerie ;
Strunk, Katja ;
Sweetman, Gavain ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel G. ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2011, 29 (03) :255-U124
[30]   Histone Deacetylase (HDAC) Inhibitors: Current Evidence for Therapeutic Activities in Pancreatic Cancer [J].
Damaskos, Christos ;
Karatzas, Theodore ;
Nikolidakis, Lampros ;
Kostakis, Ioannis D. ;
Karamaroudis, Stefanos ;
Boutsikos, Georgios ;
Damaskou, Zoi ;
Kostakis, Alkiviadis ;
Kouraklis, Gregory .
ANTICANCER RESEARCH, 2015, 35 (06) :3129-3135